August 2022 #MoleculesOfTheMonth | https://t.co/tIDCXd3z9i A covalent, proof-of-concept KRASG12R inhibitor, an oral dihydroorotate dehydrogenase inhibitor being developed for AML, and a first-in-class YAP-TEAD protein-protein are some examples of this month's MOTM. #drughunter https://t.co/xNaaDiYvjG
No comments:
Post a Comment